Biomedical (BASIC)

Ended Definitive Contract Awarded Last action

Contract number
00275200203D275023339
Awardee
Awarding agency
Obligated
$1,767,420

Award facts

Contract value 53% obligated
  • $598,304.82 Current, with exercised options
  • $3,332,304.82 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer
Pricing
Cost Plus Fixed Fee
Place of performance
San Diego, CA 92126, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 12 · Final_close_process - $0
Other Administrative Action 11 -$17,820
Other Administrative Action 5 $0
Other Administrative Action 6 $0
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Other Administrative Action 9 $0
Other Administrative Action 4 $0
Funding Only Action 10 $170,528
Other Administrative Action 3 $0
Funding Only Action 2 $445,597
Supplemental Agreement for work within scope 1 $582,115
Original award $587,000
Show all 13

About this award

This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The $3,332,304.82 cost-plus-fixed-fee contract is for biomedical (basic) research services, including the storage and stability testing of drug substances and products. The contract has no set-aside designation and was awarded on March 1, 2002 with a completion date of March 16, 2008.

In addition to this contract, Polypeptide Labs currently holds two significant Indefinite Delivery Contracts (IDCs) with other NIH agencies. The first is a $49,713,679 single-award IDC with the National Center for Advancing Translational Sciences (NCATS) for chemistry, manufacturing, and controls (CMC) services related to drug substance development. The second IDC, valued at $2,781,317, was awarded by the National Institute on Drug Abuse (NIDA) for the synthesis and distribution of opioid and related peptides over a five-year period. These IDCs demonstrate Polypeptide Labs' crucial role in supporting biomedical research and drug development efforts across multiple NIH institutes.

Quick answers

Who was awarded contract 00275200203D275023339?

00275200203D275023339 was awarded to Polypeptide Laboratories San Diego, LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on March 1, 2002.

How much is contract 00275200203D275023339 worth?

The government has obligated $1,767,420 on 00275200203D275023339. Its current value, with exercised options, is $598,305. Its potential value, with all options, is $3,332,305.

Which agency awarded contract 00275200203D275023339?

National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) awarded 00275200203D275023339, with funding from National Institute of Child Health and Human Development (National Institutes of Health).

Was contract 00275200203D275023339 competed?

The extent of competition for 00275200203D275023339 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award